Scarica l'app Stockscreener
665.30
1.03%
6.78
Dopo l'orario di chiusura:
665.30
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$658.52
Aprire:
$657.61
Volume 24 ore:
2.32M
Relative Volume:
1.13
Capitalizzazione di mercato:
$245.99B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
36.58
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
+2.60%
1M Prestazione:
+5.73%
6M Prestazione:
+39.15%
1 anno Prestazione:
+41.63%
Intervallo 1D:
$655.78
$671.47
Intervallo di 1 settimana:
$646.80
$671.47
Portata 52W:
$435.27
$671.47
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
665.30 | 243.49B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.56 | 155.42B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
390.79 | 56.35B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
165.32 | 47.16B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
267.86 | 44.46B | 16.63B | 1.39B | 2.12B | 8.0674 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher, Bird, BRS at 52-Week Highs on News - Baystreet.ca
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development - BioSpace
Thermo Fisher launches CHO-K1 cell culture media panel By Investing.com - Investing.com Canada
Thermo Fisher Scientific stock holds near its yearly high - AD HOC NEWS
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Thermo Fisher Scientific stock slips 0.20 percent ahead of the open - AD HOC NEWS
Thermo Fisher stock rises 0.30 percent at the close - AD HOC NEWS
Transport Media Market Is Going to Boom with Thermo Fisher - openPR.com
Top 3 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
Thermo Fisher Scientific stock rises 1.23 percent near its yearly high - AD HOC NEWS
Thermo Fisher Scientific stock heads into the open after a 0.51 percent gain - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Monday, still underperforms market - MarketWatch
Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today - Benzinga
Mayo Clinic, Thermo Fisher partner to create biomedical database - healthcaredive.com
Mayo Clinic, Thermo Fisher partner to create Precure - MedTech Dive
Thermo Fisher Scientific stock gains as investors eye upcoming earnings and dividend - AD HOC NEWS
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $780 From $650, Maintains Buy Rating - marketscreener.com
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Market with Strong Buy Ratings and Robust Revenue Growth - DirectorsTalk Interviews
Thermo Fisher stock ends the day higher at the close on the NYSE - AD HOC NEWS
Thermo Fisher Scientific stock eases after guidance raise and solid second-quarter growth - AD HOC NEWS
Thermo Fisher Scientific to Present at the Morgan Stanley 24th An - The National Law Review
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific (TMO) is Positioned for Resurgence - Yahoo Finance
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
What Makes Thermo Fisher Scientific (NYSE) Worth Watching Now? - kalkinemedia.com
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Three Analysts, Three Verdicts on Thermo Fisher: Here’s Who the Numbers Favor - Yahoo Finance
Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform? - Yahoo Finance
Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’ - Yahoo Finance
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
A Look at Thermo Fisher Scientific Inc (TMO) After 4.5% Gain -- GF Value $598.67 vs Price $641.39 - GuruFocus
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.44% on Sep 15: Facts Behind the Movement - TradingKey
Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear - Mayo Clinic News Network
About Thermo Fisher Scientific rStock - Coinbase
Thermo Fisher Scientific Inc. (TMO) latest stock news and headlines - Yahoo Finance UK
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Thermo Fisher stock gains on UBS upgrade and solid Q2 growth - ad-hoc-news.de
Thermo Fisher Scientific Share Price Today (TMO) | Live Chart, News & Stock Market - TechGraph
Thermo Fisher Drew Two Upgrades Near Its Highs. Here’s Where the Stock Could Go - TIKR.com
Thermo Fisher stock gains analyst support as UBS lifts target to 730 dollars - ad-hoc-news.de
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’ - Benzinga
Thermo Fisher stock heads into the open after a 0.4% loss - ad-hoc-news.de
UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540 - Moomoo
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
UBS upgrades Thermo Fisher Scientific stock rating on growth outlook By Investing.com - Investing.com Canada
Thermo Fisher stock slips as dividend date nears - ad-hoc-news.de
Thermo Fisher stock heads into the open after a 1.75 percent drop - AD HOC NEWS
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):